Limited humoral and specific T-cell responses after SARS-CoV-2 vaccination in PWH with poor immune reconstitution
S Benet, O Blanch-Lombarte… - The Journal of …, 2022 - academic.oup.com
Background We analyzed humoral and cellular immune responses induced by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines in …
respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines in …
[HTML][HTML] Impact on HIV-1 RNA levels and antibody responses following SARS-CoV-2 vaccination in HIV-infected individuals
V Portillo, C Fedeli, P Ustero Alonso, I Petignat… - Frontiers in …, 2022 - frontiersin.org
This study aims to assess the immunological response and impact on virological control of
the mRNA vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
the mRNA vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Humoral and cellular immune response elicited by mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in people living with …
Abstract Background Data on SARS-CoV-2 vaccine immunogenicity in PLWH are currently
limited. Aim of the study was to investigate immunogenicity according to current CD4 T-cell …
limited. Aim of the study was to investigate immunogenicity according to current CD4 T-cell …
[HTML][HTML] Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV
We identified determinants of SARS-CoV-2 mRNA vaccine antibody response in people with
HIV (PWH). Antibody response was higher among PWH less than 60 years, with CD4+ cell …
HIV (PWH). Antibody response was higher among PWH less than 60 years, with CD4+ cell …
Differences in post-mRNA vaccination severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) concentrations and surrogate virus …
Following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA
vaccination, people living with human immunodeficiency virus (HIV, PLWH) had lower …
vaccination, people living with human immunodeficiency virus (HIV, PLWH) had lower …
Reduced neutralizing antibody response to SARS‐CoV‐2 vaccine booster dose in people living with HIV with severe immunosuppression
A Corma‐Gómez, M Fernández‐Fuertes… - Journal of Medical …, 2023 - Wiley Online Library
The aim of this study was to assess the immunogenicity of severe acute respiratory
syndrome coronavirus 2 (SARS‑CoV‑2) vaccines among people living with HIV (PLWH) with …
syndrome coronavirus 2 (SARS‑CoV‑2) vaccines among people living with HIV (PLWH) with …
[HTML][HTML] Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study
Y Feng, Y Zhang, Z He, H Huang, X Tian, G Wang… - …, 2022 - thelancet.com
Background Inactivated COVID-19 vaccines are safe and effective in the general population
with intact immunity. However, their safety and immunogenicity have not been demonstrated …
with intact immunity. However, their safety and immunogenicity have not been demonstrated …
Robust vaccine-induced as well as hybrid B-and T-cell immunity across SARS-CoV-2 vaccine platforms in people with HIV
Few studies have comprehensively compared severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccine-induced and hybrid B-and T-cell responses in people …
coronavirus 2 (SARS-CoV-2) vaccine-induced and hybrid B-and T-cell responses in people …
[HTML][HTML] Surrogate neutralization responses following severe acute respiratory syndrome coronavirus 2 vaccination in people with HIV: comparison between …
NS Wong, BCK Wong, JMC Chan, KH Wong… - Aids, 2022 - journals.lww.com
Objective: People with HIV (PWH) co-infected with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are at higher odds of severe diseases. Whereas the …
coronavirus 2 (SARS-CoV-2) are at higher odds of severe diseases. Whereas the …
[HTML][HTML] Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV
A Corma-Gómez, M Fernández-Fuertes… - Clinical Microbiology …, 2022 - Elsevier
Objectives The aim of this study was to assess the immunogenicity of SARS-CoV-2 available
vaccines among people living with HIV (PLWH) after a complete vaccination scheme, and …
vaccines among people living with HIV (PLWH) after a complete vaccination scheme, and …